FastPlex™ Triplex SARS-CoV-2 Detection Kits
qPCR (CE) and Digital PCR assays (FDA-EUA) for Coronavirus (COVID-19)
PreciGenome FastPlex Triplex SARS-CoV-2 Detection Kit is a fast, highly sensitive multiplex diagnostic solution. It consists of both the assays and controls, which are needed for the real-time PCR RNA detection from the SARS-CoV-2 virus. It is a multiplex RT-PCR diagnostic kit, enabling quick and precise diagnosis of COVID-19 caused by SARS-CoV-2 infection.
FastPlex™ 1 Step SARS-CoV-2 Detection Kit (RT-PCR)
Catalog #: 02.01.1020
The 1 step SARS-CoV-2 detection kit is based on the PCR method which uses a fluorescent probe and a specific primer to detect two specific regions within the novel coronavirus (SARS-CoV-2) nucleocapsid protein N gene. This molecular panel aids in the detection of viral RNA from SARS-CoV-2, the causative agent of COVID-19. The kit is used with Rainamp™ VTM with proprietary releasing agent which enables the user to use crude Nasal or throat swabs directly in their PCR reactions. By simply mixing the Rainamp VTM with the sample, the viral RNA is immediately stabilized, and can be released efficiently with extraction step. This eliminates the need for laborious, costly RNA extraction and purification steps, drastically improving upon the traditional workflow of PCR, while removing potential sample loss and contamination.
-
Workflow
-
Kit Components
Catalog #: 02.01.1020
* FastPlex 1 Step SARS-CoV-2 Detection Kit (RT-PCR) is a CE marked product, and for In Vitro Diagnostic Use.
* FastPlex 1 Step SARS-CoV-2 Detection Kit (RT-PCR) is not FDA cleared.
-
Documents
FastPlex™ Triplex SARS-CoV-2 Detection Kit (RT-PCR)
Catalog #: 02.01.1038
-
Detection Principle
This kit uses the 2019-Novel Coronavirus (Covid-19) ORF 1ab and the specific conserved sequence encoding the nucleocapsid protein N gene as the target regions to carry out the dual-target genes design. A one-step reverse transcription-polymerase chain reaction (RT-PCR) combined with Taqman hydrolysis probe technology was used to detect the RNAs in the sample by a fluorescence quantitative PCR instrument with changes in fluorescence signal.
The PCR detection kit includes endogenous internal standard primers and probes and monitors the sample collection and extraction process by detecting whether the internal standard is normal to avoid false-negative results.
Typical S-shape amplification curves for postive SARS-CoV-2 specimens
Amplification curves for negative SARS-CoV-2 specimens
-
Assay information
-
Kit Components
Catalog #: 02.01.1038
* FastPlex Triplex SARS-CoV-2 Detection Kit (RT-PCR) is a CE marked product, and for In Vitro Diagnostic Use.
* FastPlex Triplex SARS-CoV-2 Detection Kit (RT-PCR) is not FDA cleared.
-
Sample Requirements
1. Applicable sample types: upper respiratory tract samples (including throat swabs, nasal swabs, nasopharyngeal extracts, deep cough sputum); lower respiratory tract samples (including respiratory tract extracts, bronchial lavage fluid, lung tissue biopsy samples).
2. Sample collection: Collect according to the conventional sample collection method.
3. Sample storage and transportation: The collected specimens should be submitted for analysis in time, or stored at 4°C for 24 hours; it is best to store at -70°C for more than 24 hours and avoid repeated freeze-thaw cycles.
-
Documents
Performance Characteristics
FastPlex™ Triplex SARS-CoV-2 Detection Kit (RT-Digital PCR)
Catalog #: 02.01.1019
-
Detection Principle
This kit employs digital PCR technology combined with Taqman fluorescent probe, and provides qualitative detection of the 2019-Novel Coronavirus (Corvid-19).
The sample is randomly partitioned upto 25 thousand partitions, where PCR reaction is then performed. After the PCR reaction, the fluorescent signal from each partition is acquired and further analyzed based on Poisson distribution. As a result, genes specific to SARS-CoV-2 can be detected with high precision.
In particular, the Covid-19 ORF1ab probe contains FAM label, E gene probe contains HEX label, and RRP30 is used as reference gene with Cy5 label.
-
Assay information
-
Kit Components
* FastPlex Triplex SARS-CoV2 Detection Kits (RT-Digital PCR) are sold for Emergency Use Authorization (EUA) only. For in vitro diagnostic use.
-
Documents
FDA EUA Approved Documents: IFU, Fact Sheet For Patients, Fact Sheet For Providers.
FastPlex™ SARS-CoV-2 and Influenza A & B Detection Kit (RT-PCR)
Catalog #: 02.01.1042
-
Features
-
One tube detects Influenza A, influenza B and SARS-CoV-2 simultaneously.
-
FAM channel detects SARS-CoV-2, HEX channel detects Influenza A, Cy5 channel detects Influenza B,ROX channel detects Human internal reference gene as quality control
-
Compatible with most 96 well plate real time fluorescence PCR instruments
-
< 250 copies/ml LoD for flu A, flu B and COVID-19 virus
-
Less than 90 minutes sample to results
-
Best screening tool during flu season and COVID-19 pandemic
COVID-19 Lab Guidance & Diagnostics
Lab Guidance
-
Laboratory guidelines for detection and diagnosis of the novel coronavirus (2019-nCoV) infection (PAHO)
Diagnostics
-
Coronavirus (COVID-19) update: FDA issues new policy to help expedite availability of diagnostics (FDA news release, Feb 29, 2020)
-
FDA’s actions in response to 2019 novel coronavirus at home and abroad (FDA statement, Feb 14, 2020)
-
FDA takes significant step in coronavirus response efforts, issues Emergency Use Authorization for the first 2019 novel coronavirus diagnostic (FDA news release, Feb 4, 2020)
-
FDA announces key actions to advance development of novel coronavirus medical countermeasures (FDA news release, Jan 27, 2020)
-
CDC tests for COVID-19 (CDC)
-
Real time RT-PCR panel for detection of 2019-novel coronavirus (CDC)
-
2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes (CDC)
-
Testing in the US (CDC)
-
Shipping of CDC 2019 novel coronavirus diagnostic test kits begins (CDC news release, Feb 6, 2020)
-
Diagnostic testing for 2019-nCoV (Johns Hopkins fact sheet, Jan 28, 2020)
-
HHS seeks abstract submissions for 2019-nCoV diagnostics development (US HHS news release, Feb 5, 2020)
FastPlex™ SARS-CoV-2 Detection & Identification Kit for Delta, UK, and South Africa Variants (RT-PCR)
Catalog #: 02.01.1022
Catalog #: 02.01.1040
Catalog #: 02.01.1044
-
Features
-
UK B.1.1.7, South Africa B.1. 351 and Brazil P1 variants identification
-
Compatible with most 96 well plate real time fluorescence PCR instruments
-
< 250 copies/ml LoD for flu A, flu B and COVID-19 virus
-
Less than 90 minutes sample to results with regular 96-well PCR instrument
-
Less than 45 minutes sample to results with portable mini PCR instrument for fast detection
-
Best screening tool during flu season and COVID-19 pandemic
References
-
(2020) 2019-Novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes. US Centers for Disease Control and Prevention.
-
(2020) 2019 Novel Coronavirus (2019-nCoV), Wuhan, China. [Online] US Centers for Disease Control and Prevention.
-
(2020) Real-time RT-PCR panel for detection 2019-novel coronavirus. US Centers for Disease Control and Prevention.
-
(2020) Emergency use authorization. [Online] US Centers for Disease Control and Prevention.